Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Howard

<< Previous

Bullboard Posts

Next >>

Comment by MirrorWorldManon Feb 28, 2024 4:34pm

88 Views

Post# 35904898

RE:RE:Howard

It's also tragic that he approves his own loan with generous terms, and also being the only one that knows the AbbVie deal numbers. If that isn't using insider knowledge for personal gain then what is? Assume that SkiimMedica doesn't launch and pays Serona a penalty... then Howie just uses that money to pay himself back his own loan. He is using this own company as a bank to pay himself. We suffer.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments